Looking at Quantum’s half-year to end-March results now, a few punters might wonder if the ructions were justified

A rejigged Long4Life, it might be argued, would not really hold a portfolio that justifies a continued listing. I disagree

In June last year, when Covid was just starting to rage in SA, CMH trundled down to under R10 on the JSE. The share has since doubled

At the moment the share price is asking some serious questions

I wonder if Mediclinic, which is still convalescing from this prolonged bout of Covid, would not be thinking of taking another tilt at Spire?

The JSE was hardly a calm pond this week, and a variety of corporate actions are causing some serious ripples

Flipping through Astoria’s recent annual report has made me think twice

Ascendis CEO Mark Sardi likened the health-care conglomerate to “driving a Ferrari with the handbrake on”

Apparently there is a 40% return to be made on Grand Parade Investments if investors back management’s efforts to realise assets and unlock value

CEO Anthony Leeming is doing a fine job keeping a lid on costs and driving efficiencies

It’s a brave buyer willing to take over a local fishing entity while the Frap is still bobbing around on a tide of uncertainty

British American Tobacco listed on the Nasdaq? That would look out of place. But some folks are taking this smoky speculation quite seriously

Sea Harvest has pulled off an astounding turnaround in its Australian business

I did not expect consistently profitable logistics counter Value Group to test shareholders around a buyout offer and delisting

Agri-services conglomerate Kaap Agri probably deserves wider recognition for its success in cornering a superb retail niche with its Agrimark brand(s)

I’d back Astral all the way, unlike some shareholders who bizarrely voted down the company’s remuneration resolution